Evidence map›Paper›PMID 27681418›Full record

ArticleCell reports2016

mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.

Annabel Y Minard, Shi-Xiong Tan, Pengyi Yang, Daniel J Fazakerley, Westa Domanova, Benjamin L Parker, Sean J Humphrey, Raja Jothi, Jacqueline Stöckli, David E James

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 120 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Annabel Y MinardThe Garvan Institute of Medical Research, Sydney, NSW 2010, Australia; Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Shi-Xiong TanInstitute of Molecular and Cell Biology, Singapore 138673, Singapore.
Pengyi YangCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia; School of Mathematics and Statistics, University of Sydney, Sydney, NSW 2006, Australia.
Daniel J FazakerleyCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Westa DomanovaCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Benjamin L ParkerCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Sean J HumphreyCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
Raja JothiSystems Biology Section, Epigenetics & Stem Cell Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
Jacqueline StöckliCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.
David E JamesCharles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia; School of Medicine, University of Sydney, Sydney, NSW 2006, Australia. Electronic address: david.james@sydney.edu.au.
University of Sydney · AUInstitute of Molecular and Cell Biology · SGNational Institutes of Health · US

Funding

Gene regulatory elements, networks, and mechanismsZIAES102625 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI JOTHI, RAJA · 2009 to 2025
$27.4M
Intramural NIH HHS ZIA ES102625
6 · The paper itself

Abstract

FGF21 improves the metabolic profile of obese animals through its actions on adipocytes. To elucidate the signaling network responsible for mediating these effects, we quantified dynamic changes in the adipocyte phosphoproteome following acute exposure to FGF21. FGF21 regulated a network of 821 phosphosites on 542 proteins. A major FGF21-regulated signaling node was mTORC1/S6K. In contrast to insulin, FGF21 activated mTORC1 via MAPK rather than through the canonical PI3K/AKT pathway. Activation of mTORC1/S6K by FGF21 was surprising because this is thought to contribute to deleterious metabolic effects such as obesity and insulin resistance. Rather, mTORC1 mediated many of the beneficial actions of FGF21 in vitro, including UCP1 and FGF21 induction, increased adiponectin secretion, and enhanced glucose uptake without any adverse effects on insulin action. This study provides a global view of FGF21 signaling and suggests that mTORC1 may act to facilitate FGF21-mediated health benefits in vivo.

Indexed as

3T3-L1 CellsAdipocytesAdiponectinAnimalsCell DifferentiationDeoxyglucoseFibroblast Growth FactorsGene Expression RegulationGene Regulatory NetworksInjections, IntraperitonealIsotope LabelingMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMultiprotein ComplexesPhosphoproteinsAdiponectinAdipoq protein, mouseDeoxyglucosefibroblast growth factor 21Fibroblast Growth FactorsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesPhosphoproteinsProteomeProto-Oncogene Proteins c-aktRibosomal Protein S6 Kinases, 90-kDaRps6ka1 protein, mouseSirolimusTOR Serine-Threonine KinasesUcp1 protein, mouseUncoupling Protein 1adipocyteFGF21insulin resistancemTORmTORC1obesityphosphoproteomephosphoproteomicssignalingUCP1

Identifiers

PMID27681418
PMCPMC6485955
OpenAlexW2527640953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.